Levothyroxine Sodium Tablets, USP, 112 mcg (0.112 mg), 100 Tablets per carton (10 unit dose blist...
FDA Recall #D-0132-2025 — Class II — November 19, 2024
Product Description
Levothyroxine Sodium Tablets, USP, 112 mcg (0.112 mg), 100 Tablets per carton (10 unit dose blister cards of 10 tablets each), Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 USA. NDC: 42292-039-20
Reason for Recall
Subpotent and Superpotent Drug
Recalling Firm
Mylan Institutional, Inc. — Rockford, IL
Classification
Class II — May cause temporary or medically reversible adverse health consequences.
Product Type
Drugs
Product Quantity
988 cartons
Distribution
Nationwide in the USA.
Code Information
Lot #: 3115707, Exp. Date 02/2025
Status
Ongoing
Voluntary / Mandated
Voluntary: Firm initiated